Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66

1.

HIV and multidrug-resistant tuberculosis: overlapping risk factors.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Ismailov S.

Eur Respir J. 2015 Feb;45(2):567-9. doi: 10.1183/09031936.00131014. No abstract available.

PMID:
25653273
2.

Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.

Durovni B, Saraceni V, van den Hof S, Trajman A, Cordeiro-Santos M, Cavalcante S, Menezes A, Cobelens F.

PLoS Med. 2014 Dec 9;11(12):e1001766. doi: 10.1371/journal.pmed.1001766. eCollection 2014 Dec.

3.

High positive predictive value of Xpert in a low rifampicin resistance prevalence setting.

Trajman A, Durovni B, Saraceni V, Cordeiro-Santos M, Cobelens F, van den Hof S.

Eur Respir J. 2014 Dec;44(6):1711-3. doi: 10.1183/09031936.00115514. Epub 2014 Sep 3. No abstract available.

PMID:
25186257
4.

Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil.

Durovni B, Saraceni V, Cordeiro-Santos M, Cavalcante S, Soares E, Lourenço C, Menezes A, van den Hof S, Cobelens F, Trajman A.

Bull World Health Organ. 2014 Aug 1;92(8):613-7. doi: 10.2471/BLT.13.131409. Epub 2014 May 1.

5.

The epidemiology of childhood tuberculosis in the Netherlands: still room for prevention.

Erkens CG, de Vries G, Keizer ST, Slump E, van den Hof S.

BMC Infect Dis. 2014 May 31;14:295. doi: 10.1186/1471-2334-14-295.

6.

Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.

Erkens CG, Dinmohamed AG, Kamphorst M, Toumanian S, van Nispen-Dobrescu R, Alink M, Oudshoorn N, Mensen M, van den Hof S, Borgdorff M, Verver S.

Int J Tuberc Lung Dis. 2014 Apr;18(4):413-20. doi: 10.5588/ijtld.13.0589.

PMID:
24670695
7.

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.

Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.

PMID:
23485387
8.

Helminths and skewed cytokine profiles increase tuberculin skin test positivity in Warao Amerindians.

Verhagen LM, Hermans PW, Warris A, de Groot R, Maes M, Villalba JA, del Nogal B, van den Hof S, Mughini Gras L, van Soolingen D, Pinelli E, de Waard JH.

Tuberculosis (Edinb). 2012 Nov;92(6):505-12. doi: 10.1016/j.tube.2012.07.004. Epub 2012 Aug 9.

PMID:
22877977
9.

Measuring workload for tuberculosis service provision at primary care level: a methodology.

Blok L, van den Hof S, Mfinanga SG, Kahwa A, Ngadaya E, Oey L, Dieleman M.

Hum Resour Health. 2012 May 28;10:11. doi: 10.1186/1478-4491-10-11.

10.

Which new diagnostics for tuberculosis, and when?

Cobelens F, van den Hof S, Pai M, Squire SB, Ramsay A, Kimerling ME; Evidence for Scale-up Group.

J Infect Dis. 2012 May 15;205 Suppl 2:S191-8. doi: 10.1093/infdis/jis188. Epub 2012 Apr 3.

11.

Integration of HIV testing in tuberculosis drug resistance surveillance in Kazakhstan and Kenya.

Klinkenberg E, van den Hof S, Tursynbayeva A, Kipruto H, Wahogo J, Pak S, Kutwa A, L'Herminez R.

Int J Tuberc Lung Dis. 2012 May;16(5):615-7. doi: 10.5588/ijtld.11.0262. Epub 2012 Mar 8.

PMID:
22409816
12.

Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China.

Yao S, Huang WH, van den Hof S, Yang SM, Wang XL, Chen W, Fang XH, Pan HF.

BMC Health Serv Res. 2011 Dec 16;11:341. doi: 10.1186/1472-6963-11-341.

13.

Multidrug-resistant tuberculosis, People's Republic of China, 2007-2009.

He GX, Wang HY, Borgdorff MW, van Soolingen D, van der Werf MJ, Liu ZM, Li XZ, Guo H, Zhao YL, Varma JK, Tostado CP, van den Hof S.

Emerg Infect Dis. 2011 Oct;17(10):1831-8. doi: 10.3201/eid1710.110546.

14.

Making innovations accessible to the poor through implementation research.

Squire SB, Ramsay AR, van den Hof S, Millington KA, Langley I, Bello G, Kritski A, Detjen A, Thomson R, Cobelens F, Mann GH.

Int J Tuberc Lung Dis. 2011 Jul;15(7):862-70. doi: 10.5588/ijtld.11.0161.

PMID:
21682960
15.

Influence of sampling on clustering and associations with risk factors in the molecular epidemiology of tuberculosis.

Borgdorff MW, van den Hof S, Kalisvaart N, Kremer K, van Soolingen D.

Am J Epidemiol. 2011 Jul 15;174(2):243-51. doi: 10.1093/aje/kwr061. Epub 2011 May 23.

16.

Risk factors for non-cure among new sputum smear positive tuberculosis patients treated in tuberculosis dispensaries in Yunnan, China.

Jianzhao H, van den Hof S, Lin X, Yubang Q, Jinglong H, van der Werf MJ.

BMC Health Serv Res. 2011 May 11;11:97. doi: 10.1186/1472-6963-11-97.

17.

Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals.

Xue He G, van den Hof S, van der Werf MJ, Guo H, Hu YL, Fan JH, Zhang WM, Tostado CP, Borgdorff MW.

Clin Infect Dis. 2011 Apr 1;52(7):e153-6. doi: 10.1093/cid/cir075.

18.

Mycobacterial factors relevant for transmission of tuberculosis.

Verhagen LM, van den Hof S, van Deutekom H, Hermans PW, Kremer K, Borgdorff MW, van Soolingen D.

J Infect Dis. 2011 May 1;203(9):1249-55. doi: 10.1093/infdis/jir013. Epub 2011 Mar 4.

19.

Improving detection and notification of tuberculosis cases in students in Shaanxi province, China: an intervention study.

Zhang T, Guo L, Zhang S, Liu W, Chen G, Hui M, He G, van der Werf MJ, van den Hof S.

BMC Public Health. 2011 Mar 4;11:147. doi: 10.1186/1471-2458-11-147.

20.

Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review.

Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M.

Thorax. 2012 Jan;67(1):62-70. doi: 10.1136/thx.2010.143180. Epub 2011 Jan 12. Review.

PMID:
21228420
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk